Mesolimbic 7-OH-DPAT affects locomotor activities in rats

Pharmacology Biochemistry and Behavior

Volumn 55, Issue 2, 1996, Pages 209-214

  Meyer, Merle E ^a  

^a University of Florida ^*  (United States)

Author keywords

7 OH DPAT; D3 receptor; Dopamine; Locomotion; Nucleus accumbens; Rat; Rearing; Sterotypy behavior; Ventral tegmental area

Indexed keywords

2 DIPROPYLAMINO 7 HYDROXYTETRALIN; DOPAMINE 3 RECEPTOR; DOPAMINE RECEPTOR STIMULATING AGENT;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; LIMBIC SYSTEM; LOCOMOTION; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RAT; STEREOTYPY; VENTRAL TEGMENTUM;

ANIMALS; DOPAMINE AGONISTS; LIMBIC SYSTEM; MICROINJECTIONS; MOTOR ACTIVITY; RATS; RECEPTORS, DOPAMINE D2; RECEPTORS, DOPAMINE D3; STEREOTYPED BEHAVIOR; TETRAHYDRONAPHTHALENES; VENTRAL TEGMENTAL AREA;

ANIMALIA;

EID: 0030272805     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(96)00066-4     Document Type: Article

References (32)

1. 3 receptor-selective ligand, 7-OH-DPAT, in the normal and reserpine-treated rat. Eur. J. Phamacol. 260:177-181; 1994.
2. 2 receptor mRNA. Brain Res. 564:203-219; 1991.
3. 3. Caine, S. B.; Koob, G. F. Modulation of cocaine self-administration in the rat through D-3 dopamine receptors. Science 250:1814-1816; 1993.
4. 4. Clark, D.; Hjorth, S.; Carlsson, A. Dopamine receptor agonists: Mechanisms underlying autoreceptor selectivity. II. Theoretical considerations. J. Neural Transm. 62:171-207; 1985.
5. 5. Daly, S. A.; Waddington, J. L. Behavioral effects of the putative D-3 dopamine receptor agonist 7-OH-DPAT in relation to other "D-2 like" agonists. Neuropharmacology 32:509-510; 1993.
6. 6. Devoto, P.; Collu, M.; Muntoni, A. L.; Pistis, M.; Serra, G.; Gessa, G. L.; Diana, M. Biochemical and electrophysiological effects of 7-OH-DPAT on the mesolimbic dopaminergic system. Synapse 20:153-155; 1995.
7. 7. Di Chiara, G.; Porceddu, M. L.; Vargiu, L.; Stefanini, E.; Gessa, G. L. Evidence of dopamine receptors mediating sedation in the mouse brain. Nature 264:564-567; 1976.
8. 3 receptor and 7-OH-DPAT. Trends Pharmacol. Sci. 15:173-174; 1994.
9. 3 receptor sites in rat brain. A comparative study using in situ hybridization histochemistry and ligand bind autoradiography. Eur. J. Neurosci. 5:145-154; 1993.
10. 3 receptor: Chinese hamsters or Chinese whispers? Trends Pharmacol. Sci. 15: 46-47; 1994.
11. 3 receptor in rat brain using 7-[3]hydroxy-N,N-di-n-propyl-2-aminotetralin. Proc. Natl. Acad. Sci. USA 89:8155-8159; 1992.
12. 3 receptor agonist 7-OH-DPAT: Lack of mesolimbic selectivity. Eur. J. Pharmacol., 264:269-278: 1994.
13. 13. Lynch, M. R. Dissociation of autoreceptor activation and behavioral consequences of low-dose apomorphine treatment. Prog. Neuropsychopharmacol. Biol. Psychiatry 15:689-698; 1991.
14. 3 receptors. Eur. J. Pharmacol. 249:R5; 1993.
15. 1 receptor family agonists, SK&F 38393, SK&F 77434 and SK&F 82958, differentially affect locomotor activities in rats. Pharmacol. Biochem. Behav. 46:269-274; 1993.
16. 1 agonist SK&F 38393 into the nucleus accumbens in rats. Synapse 13:310-314; 1993.
17. 17. Paxinos, G.; Watson, C. The rat brain stereotaxic coordinates. New York: Academic Press, Inc.; 1986.
18. 18. Schwartz, J.-C.; Giros, B.; Martres, M.-P.; Sokoloff, P. The dopamine receptor family: Molecular biology and pharmacology. Semin. Neurosci. 4:99-108; 1992.
19. 3 receptor: basic and clinical aspects. Clin. Neuropharmacol. 16:295-314; 1993.
20. 20. Seeman, P.; Van Tol, H. H. M. Dopamine receptor pharmacology. Trends Pharmacol. Sci. 15:264-270; 1994.
21. 21. Sibley, D. R.; Monsma, F. J. Molecular biology of dopamine receptors. Trends Pharmacol. Sci. 13:61-69; 1992.
22. 3) as a target for neuroleptics. Nature 347: 146-151; 1990.
23. 2 receptor. Eur. J. Pharmacol. (Mol. Biol.) 225:331-337; 1992.
24. 24. Ståhle, L. Do autoreceptors mediate dopamine agonist-induced yawning and suppression of exploration? A critical review. Psychopharmacology (Berlin) 106:1-3; 1992.
25. 25. Strömbrom, U. Catecholamine receptor agonists. Effects on motor activity and rate of tyrosine hydroxylation in mouse brain. Naunyn Schmiedebergs Arch. Pharmacol. 292:167-176; 1976.
26. 3 ligand R-(+)-7-OH-DPAT is independent of changes in dopamine release. J. Neural Transm. 95:71-74; 1994.
27. 1. Nature 350:614-619; 1991.
28. 28. Timmerman, W.; Tepper, P. G.; Dijkstra, D.; Stoelwinder, H.; Gral, C. J.; Westerink, B. H. C.; Horn, A. S. Enantiomers of monohydroxy-2-aminotetralin derivatives and their activity at dopamine autoreceptors as studied by brain dialysis. Eur. J. Pharmacol. 199:145-151; 1991.
29. 29. Van Hartesveldt, C.; Cottrell, G. A.; Potter, T.; Meyer, M. E. Effects of intracerebral quinpirole on locomotion in rats. Eur. J. Pharmacol. 214:27-32: 1992.
30. 4 receptor with affinity for the antipsychotic clozapine. Nature 350:610-614; 1991.
31. 3-receptor: A postsynaptic receptor inhibitory on rat locomotor activity. J. Nerual Transm. 94: 11-19; 1993.
32. 32. Wolf, M. E.; Roth, R. H. Dopamine autoreceptors. In: Creese, I.: Fraser, C. M., eds. New York: Alan R. Liss; 1987:45-96.